The risk of leprosy in patients using immunobiologics and conventional immunosuppressants for the treatment of dermatological and rheumatological diseases: a cohort study
Sign Up to like & getrecommendations! Published in 2020 at "Journal of the European Academy of Dermatology and Venereology"
DOI: 10.1111/jdv.16764
Abstract: Leprosy remains prevalent in developing areas, and migration renders it an increasing concern in developed countries where the incidence of immune-mediated diseases, such as psoriasis, is high. We aimed to evaluate the leprosy risk in… read more here.
Keywords: immunobiologics conventional; risk; conventional immunosuppressants; patients using ... See more keywords